蛋白质错误折叠和病理性Igg光链的聚合在瘤血液学失分症:从分子途径到临床影响
Tomáš Guman1, Ján Sýkora1, Veronika Demčáková2
1Clinic of Haematology and Oncohaematology, Faculty of Medicine, Pavol Jozef Safarik University and Louis Pasteur University Hospital in Kosice, Trieda SNP 1, 040 11, Kosice, Slovakia.
Current protein & peptide science
|January 6, 2025
概括
错误折叠的免疫球蛋白G (IgG) 轻链会导致B细胞癌的聚体瘤和脏疾病. 了解IgG错误折叠为这些持久性蛋白质折叠障碍提供了新的治疗点.
科学领域:
- 瘤血液学 瘤血液学
- 分子生物学分子生物学
- 蛋白质错折叠疾病 蛋白质错折叠疾病
背景情况:
- 新生态B细胞的转变会导致异常的单克隆性免疫球蛋白轻链生产.
- 过度的IgG轻链导致"聚体"和罕见疾病,如轻链结晶沉积病.
- 脏问题和重链沉积疾病突出显示了IgG错误折叠和聚合在血细胞失分症中.
研究的目的:
- 审查IgG轻链聚合的分子机制.
- 探索IgG轻链错折在血病学疾病中的后果.
- 讨论蛋白质折叠相关问题的治疗影响.
主要方法:
- 关于分子机制的文献综述.
- 后果分析和治疗策略.
- 讨论新的治疗点.
主要成果:
- IgG错误折叠和聚合是B细胞失分的关键病原性事件.
- 蛋白质折叠问题即使在恶性细胞被清除后也会持续存在.
- 阐明机制揭示了针对性干预的途径.
结论:
- 针对IgG错折的向治疗可以改善患者的治疗结果.
- 了解蛋白质错误折叠为瘤血液学失分症提供了创新的治疗策略.
- 对IgG轻链错折的进一步研究有望改变患者护理.
相关概念视频
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K
Proteoglycans
3.8K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.8K
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Immunoglobulin-like Cell Adhesion Molecules
3.1K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.1K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


